In healthcare, the adage “context is key” holds true—especially when considering the significant role social determinants of health (SDOH) play in influencing patient outcomes. At Archo Advocacy, we’ve harnessed the power of data, research, and strategic partnerships to address these determinants head-on, equipping pharmaceutical and biotech companies to not only understand but effectively act on these critical factors.

Table of Contents

The Core of Our Work: A Patient-Centric Strategy

Archo Advocacy’s mission has always been to bridge the gaps between healthcare organizations and the communities they serve. Our newest capability exemplifies this mission: evaluating SDOH within specific disease states through tailored market research and feedback loops derived from insights like those found in our ELAVAY reports . This initiative empowers healthcare leaders to:

• Understand the barriers patients face in accessing and adhering to therapies.

• Educate leadership within pharmaceutical organizations on patient-centric care strategies.

• Develop compliant and actionable tools for teams to address patient challenges effectively.

Elevating Insights: Turning Data into Actionable Change

From qualitative interviews to custom market research, our approach ensures that healthcare leaders gain a 360-degree view of patient needs and organizational strategies. These insights don’t remain static. Instead, they inform:

1. Leadership Engagement: Sessions designed to educate and align senior executives with the real-world struggles patients encounter, fostering an organizational commitment to change.

2. Tool Development: Strategic tools for patient-facing teams to directly address barriers such as transportation issues, financial hardships, or cultural misunderstandings.

3. Team Training: Comprehensive programs that tackle personal and systemic biases in healthcare, enhancing both individual awareness and team cohesion  .

Why Focus on Social Determinants of Health?

SDOH such as housing, education, food security, and socioeconomic conditions are not just external influences—they are critical factors that impact a patient’s ability to begin and stay on therapy. For healthcare organizations, addressing these issues is both an ethical imperative and a strategic advantage:

• Increased treatment adherence: Patients are more likely to follow prescribed therapies when their basic needs are met.

• Better patient outcomes: Addressing SDOH leads to fewer relapses, reduced hospitalizations, and overall healthier communities .

Ensuring Organizational Alignment

Effective SDOH initiatives require more than good intentions—they demand structured execution. At Archo, we:

1. Train staff to recognize and address their own biases as well as systemic disparities in healthcare.

2. Develop alignment workshops to synchronize departmental goals with patient-centered strategies.

3. Track success through metrics derived from our benchmark studies and feedback analysis .

Building Toward a Better Future

Healthcare is not just about the pills in a bottle—it’s about ensuring those pills make it into the hands of patients who need them, along with the support systems that enable their efficacy. By tackling SDOH through insightful research, dynamic leadership engagement, and robust training, Archo Advocacy is setting a new standard in patient-centered care.

Let’s collaborate to ensure that no patient is left behind, and every organization is empowered to create meaningful change. Reach out to learn more about how our solutions can transform your approach to patient support and advocacy. Together, we can elevate the standard of care—one patient at a time.